ELIZABETH RICE: Open Payments
NPI 1568913051 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 51 payments from 13 companies in 2025. Trend: 2023 $1,096 · 2024 $1,506 · 2025 $1,336
Food & beverage: $1,247Education: $89
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $333 |
| Abbott Laboratories | 2 | $265 |
| Actelion Pharmaceuticals US, Inc. | 2 | $111 |
| Alnylam Pharmaceuticals Inc. | 1 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| PFIZER INC. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $64 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| CVRx, Inc. | 3 | $46 |
Products named: CARDIOMEMS, Briviact, OPSUMIT, AMVUTTRA, LEQVIO, Zilbrysq, JARDIANCE, Nayzilam.
Industry payments across TX — which companies pay providers there.
